Hui Li

Title: Hui Li - Innovator in Eyedrop Technology

Introduction

Hui Li is a notable inventor based in Qingdao, China. He has made significant contributions to the field of medical technology, particularly in the development of eyedrop solutions for treating limbal stem cell deficiency. His innovative approach has the potential to improve the quality of life for patients suffering from this condition.

Latest Patents

Hui Li holds a patent for an eyedrop applicable to limbal stem cell deficiency and its preparation method. The patent details a formulation that includes 1 to 40 mg of human adipose-derived stem cell exosomes per liter, along with excipients such as 0.5 to 2 g of sodium hyaluronate, 0.5 to 3 g of vitamin B6, and 0.05 to 0.3 g of benzalkonium chloride. The balance consists of medical normal saline, with a pH range of 6.5 to 7.5. This eyedrop has shown effectiveness in treating limbal stem cell deficiency, marking a significant advancement in ocular therapies. Hui Li has 1 patent to his name.

Career Highlights

Throughout his career, Hui Li has worked with prominent companies, including Qingdao Haier Biotech Co., Ltd and Unilever IP Holdings B.V. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in biotechnology.

Collaborations

Hui Li has collaborated with talented individuals in his field, including Qilong Cao and Fei Wang. These partnerships have fostered a creative environment that encourages the development of innovative solutions in medical technology.

Conclusion

Hui Li's contributions to the field of eyedrop technology demonstrate his commitment to improving healthcare solutions. His innovative patent and collaborations highlight his role as a key figure in advancing medical treatments for limbal stem cell deficiency.